$0.605100
-0.02-3.28%
Pre-Market: 4:50 PM EDT
Comments
Loading...
Quoin Pharmaceuticals (QNRX) Forecast
NewsEarningsQuoin Pharmaceuticals (QNRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestQuoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary
Quoin Pharmaceuticals Stock (NASDAQ: QNRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Quoin Pharmaceuticals (QNRX) stock?
You can purchase shares of Quoin Pharmaceuticals (NASDAQ:QNRX) through any online brokerage.
Who are Quoin Pharmaceuticals (QNRX) competitors?
Other companies in Quoin Pharmaceuticals’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA), Alaunos Therapeutics (NASDAQ:TCRT) and Theriva Biologics (AMEX:TOVX).
What is the forecast, or price target, for Quoin Pharmaceuticals (QNRX) stock?
Quoin Pharmaceuticals has a consensus price target of $8.50.
What is the current price for Quoin Pharmaceuticals (QNRX)?
The stock price for Quoin Pharmaceuticals (NASDAQ: QNRX) is $0.6051 last updated November 20, 2024 at 4:50 PM EST.
Does Quoin Pharmaceuticals (QNRX) pay a dividend?
There are no upcoming dividends for Quoin Pharmaceuticals.
When is Quoin Pharmaceuticals (NASDAQ:QNRX) reporting earnings?
Quoin Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Quoin Pharmaceuticals (QNRX) going to split?
There is no upcoming split for Quoin Pharmaceuticals.
What sector and industry does Quoin Pharmaceuticals (QNRX) operate in?
Quoin Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.